References
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to lowering cholesterol. JAMA 1984: 251 (3): 365–74
- Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325, 348 men screened for the MRFIT (Multiple Risk Factor Intervention Trial). Am Heart J 1986: 112(4): 825–36
- Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987: 317 (20): 1237–45
- US Department of Health and Human Services. Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Bethesda: National Institutes of Health, 1989: NIH publication No. 89–2925
- Van Horn LV. Meeting the demands of the National Cholesterol Education Program: some ideas from the field. J Am Diet Assoc 1988: 88(2): 161–2
- Smith DA, Karmally W, Brown WV. Treating hyperlipidemia. II. Making dietary control work in the elderly. Geriatrics 1987: 42(7): 39–40, 42–3
- Van Horn LV, Liu K, Parker D, et al. Serum lipid response to oat product intake with a fat-modified diet. J Am Diet Assoc 1986: 86(6): 759–64
- Castelli WP, Griffin GC. How to help patients cut down on saturated fat: a simple strategy. Postgrad Med 1988: 84(3): 44–56
- Hachfeld L, Eykyn B. Cooking à la heart: delicious heart healthy recipes from the Mankato Heart Health Program. Mankato, MN: Appletree Press, 1988
- Griffin GC, Castelli WP. Good fat, bad fat: how to lower your cholesterol and beat the odds of a heart attack Tucson: Fisher Books, 1989
- Miller M, Mead L, Kwiterivich PO, et al. Lipid abnormalities in coronary disease patients with “desirable” cholesterol levels: should we screen all CAD patients for low HDL levels? Presented before 61st Scientific Session of the American Heart Association, 1988 Nov
- Ginsberg GS, Safran C, Pasternak RC. National Cholesterol Education Program guidelines: the impact of missing HDL. Presented before 61st Scientific Session of the American Heart Association, 1988 Nov
- Smith DA, Karmally W, Brown WV. Treating hyperlipidemia. III. Drug therapy. Geriatrics 1987: 42(8): 55–9, 62
- The Lovastatin Study Group II. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia: a multicenter study. JAMA 1986: 256(20): 2829–34
- Repka FJ, Leighton RF. Step management of hypercholesterolemia. Am Fam Physician 1987: 36(4): 238–48